Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
The 7-peptide formulation of ELI-002 is designed to stimulate an immune response against seven KRAS mutations that drive 25% of...
Day: January 11, 2024
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
Mr. McCarrey brings a strong track record of success and deep experience in regenerative medicine marketsPOMPANO BEACH, Fla., Jan. 11,...
Nexalin Technology Unveils Next-Generation HALO™ Clarity
HALO™ Clarity headset Photo: HALO™ Clarity headset A new neurostimulation device to combat the growing global mental health epidemic Designed...
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference
MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries
DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)...
TransCode Therapeutics Announces 1-for-40 Reverse Stock Split
BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™...
Alira Health and Sancare Join Forces to Drive Healthcare Innovation in France
FRAMINGHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm, and Sancare, an...
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery,...
QIAGEN N.V. to release results for Q4 2023 and hold webcast
Venlo, The Netherlands, Jan. 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to...
Praxis Precision Medicines, Inc. Announces Pricing of $150.0 Million Public Offering
BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023
ORION CORPORATION STOCK EXCHANGE RELEASE - OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 11 JANUARY 2024 at...
The Joint Corp. Reports 2023 Operating Metrics
- Grows Annual System-Wide Sales 12%, Compared to 2022 -- Increases Comp Sales of 4%, Compared to 2022 - -...
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
REGENETEN Patch 2024 Smith+Nephew's REGENETEN Bioinductive Implant First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator...
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
-- Brooks Rehabilitation Hospital adds a second site to the registrational program in stroke, and brings the total number of...
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:...
TELUS Health and Clinia join forces to transform health navigation and personalize care
TELUS Ventures invests in Clinia to accelerate growth leading CAD $10M Series A financing round Partnership to revolutionize healthcare experience...
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024...
Vistin Pharma ASA: Dividend of NOK 0.75 per share
Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for...